Functional polarization of tumour-associated macrophages by tumour-derived lactic acid
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Macrophages have an important role in the maintenance of tissue homeostasis. To perform this function, macrophages must have the capacity to monitor the functional states of their 'client cells': namely, the parenchymal cells in the various tissues in which macrophages reside. Tumours exhibit many features of abnormally developed organs, including tissue architecture and cellular composition. Similarly to macrophages in normal tissues and organs, macrophages in tumours (tumour-associated macrophages) perform some key homeostatic functions that allow tumour maintenance and growth. However, the signals involved in communication between tumours and macrophages are poorly defined. Here we show that lactic acid produced by tumour cells, as a by-product of aerobic or anaerobic glycolysis, has a critical function in signalling, through inducing the expression of vascular endothelial growth factor and the M2-like polarization of tumour-associated macrophages. Furthermore, we demonstrate that this effect of lactic acid is mediated by hypoxia-inducible factor 1α (HIF1α). Finally, we show that the lactate-induced expression of arginase 1 by macrophages has an important role in tumour growth. Collectively, these findings identify a mechanism of communication between macrophages and their client cells, including tumour cells. This communication most probably evolved to promote homeostasis in normal tissues but can also be engaged in tumours to promote their growth.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, tumor cells produce lactate which induces the M2 phenotype of TAMs via stabilizing HIF‐1α and activating G‐protein‐coupled receptor 132 [210, 233, 234].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [233]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Cancer cells compete with immune cells for glucose uptake (by SLC2A1/GLUT1), produce lactic acid (by LDHA), and generate an acidic extracellular milieu (through the activity of CA9), all of which are immunosuppressive (77–86).”
From HIF inhibitor 32-134D eradicates murine hepatocellular carcinoma in combination with anti-PD1 therapy (2022) · cites this paper as [81]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Lactate is known to promote tumor growth [142], angiogenesis [143], and polarize macrophages to express a pro-tumor M2 phenotype [144].”
From Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma (2023) · cites this paper as [144]
The cited source says what the claim attributes to it.
In the citing paper
“Previous studies have demonstrated that lactate can improve the stability of the HIF-1α protein [9–11].”
From Lactylation modification of HIF-1α enhances its stability by blocking VHL recognition (2025) · cites this paper as [9]
The cited source says what the claim attributes to it.
In the citing paper
“These findings indicate that lactate derived from the tumor microenvironment might facilitate HIF-1α-regulated angiogenesis in a hypoxia-independent manner [9].”
From Lactylation modification of HIF-1α enhances its stability by blocking VHL recognition (2025) · cites this paper as [9]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Tumor angiogenesis: therapeutic implications
Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187
Protective and pathogenic functions of macrophage subsets
Murray, P. J., & Wynn, T. A. (2011) · Nature Reviews Immunology · doi:10.1038/nri3073 · Cited by 5,269
Macrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B.-Z., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,188
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
Shweiki, D., Itin, A., Soffer, D., & Keshet, E. (1992) · Nature · doi:10.1038/359843a0 · Cited by 4,617
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth
O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., & Folkman, J. (1997) · Cell · doi:10.1016/s0092-8674(00)81848-6 · Cited by 4,486
Alternative activation of macrophages: mechanism and functions
Gordon, S., & Martinez, F. O. (2010) · Immunity · doi:10.1016/j.immuni.2010.05.007 · Cited by 4,197
Cited by
Items 201–300 of 1,014
Metabolic and Epigenetic Coordination of T Cell and Macrophage Immunity
Phan, A. T., Goldrath, A. W., & Glass, C. K. (2017) · Immunity · doi:10.1016/j.immuni.2017.04.016 · Cited by 293
“For example, lactic acid produced by tumor cells, as a by-product of aerobic or anaerobic glycolysis, dramatically alters gene expression and functional polarization of tumor-associated macrophages as well as infiltrating T cells (Figure 3; Colegio et al., 2014; Brand et al., 2016).”
Petty, A. J., Li, A., Wang, X., Dai, R., Heyman, B., Hsu, D., Huang, X., & Yang, Y. (2019) · Journal of Clinical Investigation · doi:10.1172/jci128644 · Cited by 287
“Given that chemokines play an important role in the recruitment of effector CD8 + T cells, we first examined whether ers Arg-1, CD206, IL-10, TGF-β 1, and Chil3 and downregulation of the M1 markers TNF-α , iNOS, and IL-6, comparable to the same level induced by IL-4, a known M2 activator (ref.”
BackgroundInfluentialLactate supports a metabolic-epigenetic link in macrophage polarization
Noe, J. T., Rendon, B. E., Geller, A. E., Conroy, L. R., Morrissey, S. M., Young, L. E. A., Bruntz, R. C., Kim, E. J., Wise-Mitchell, A., Barbosa de Souza Rizzo, M., et al. (2021) · Science Advances · doi:10.1126/sciadv.abi8602 · Cited by 283
Ding, J., Karp, J. E., & Emadi, A. (2017) · Cancer Biomarkers · doi:10.3233/cbm-160336 · Cited by 287
“Lactic acid alone was sufficient to induce VEGF and Arg1 expression in macrophages in a dose-dependent manner [41].”
Metabolism shapes the tumor microenvironment
Reina-Campos, M., Moscat, J., & Diaz-Meco, M. (2017) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2017.05.006 · Cited by 293
TNF Counterbalances the Emergence of M2 Tumor Macrophages
Kratochvill, F., Neale, G., Haverkamp, J. M., Van de Velde, L.-A., Smith, A. M., Kawauchi, D., McEvoy, J., Roussel, M. F., Dyer, M. A., Qualls, J. E., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.08.033 · Cited by 277
“Arg1flox/flox mice have been described elsewhere and were crossed to Tie2-Cre mice (El Kasmi et al., 2008).”
BackgroundResultInfluentiall -Arginine Depletion Blunts Antitumor T-cell Responses by Inducing Myeloid-Derived Suppressor Cells
Fletcher, M., Ramirez, M. E., Sierra, R. A., Raber, P., Thevenot, P., Al-Khami, A. A., Sanchez-Pino, D., Hernandez, C., Wyczechowska, D. D., Ochoa, A. C., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-1491 · Cited by 281
“Also, in agreement with the role of cellular stress in the regulation of myeloid cells function and accumulation, recent studies showed the effect of L-Arg starvation on macrophage responses to infections (41) and the specific role of stress mediators in the induction of VEGF, arginase I (47), and MDSC accumulation (4…”
Yang, X., Lu, Y., Hang, J., Zhang, J., Zhang, T., Huo, Y., Liu, J., Lai, S., Luo, D., Wang, L., et al. (2020) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-20-0111 · Cited by 277
Bai, R., Li, Y., Jian, L., Yang, Y., Zhao, L., & Wei, M. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01645-2 · Cited by 279
“in vitro study showed that lactate induces VEGF expression and M2-like polarization of TAMs, both of which are mediated by HIF-1α [107].”
BackgroundMechanisms driving the immunoregulatory function of cancer cells
van Weverwijk, A., & de Visser, K. E. (2023) · Nature Reviews Cancer · doi:10.1038/s41568-022-00544-4 · Cited by 272
Mitochondria as central hub of the immune system
Breda, C. N. D. S., Davanzo, G. G., Basso, P. J., Saraiva Câmara, N. O., & Moraes-Vieira, P. M. M. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101255 · Cited by 279
High salt reduces the activation of IL-4– and IL-13–stimulated macrophages
Binger, K. J., Gebhardt, M., Heinig, M., Rintisch, C., Schroeder, A., Neuhofer, W., Hilgers, K., Manzel, A., Schwartz, C., Kleinewietfeld, M., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci80919 · Cited by 281
Unravelling the Interplay between Extracellular Acidosis and Immune Cells
Erra Díaz, F., Dantas, E., & Geffner, J. (2018) · Mediators of Inflammation · doi:10.1155/2018/1218297 · Cited by 269
“Low pH has been shown to increase cancer cell motility by stimulating cytoskeletal-dependent cancer cell polarization and by increasing the proteolytic activity of TAMs, fibroblasts, and the tumor cells themselves promoting both angiogenesis and cancer invasiveness [129–132].”
BackgroundInflammation: the incubator of the tumor microenvironment
Denk, D., & Greten, F. R. (2022) · Trends in Cancer · doi:10.1016/j.trecan.2022.07.002 · Cited by 273
Contribution of metabolic reprogramming to macrophage plasticity and function
EL Kasmi, K. C., & Stenmark, K. R. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.09.001 · Cited by 277
Tumor-derived exosomes in the regulation of macrophage polarization
Baig, M. S., Roy, A., Rajpoot, S., Liu, D., Savai, R., Banerjee, S., Kawada, M., Faisal, S. M., Saluja, R., Saqib, U., et al. (2020) · Inflammation Research · doi:10.1007/s00011-020-01318-0 · Cited by 267
Ždralević, M., Brand, A., Di Ianni, L., Dettmer, K., Reinders, J., Singer, K., Peter, K., Schnell, A., Bruss, C., Decking, S.-M., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.004180 · Cited by 255
“Last but not least, lactic acid is involved in tumor immune response (39, 40).”
BackgroundMetabolic reprogramming of macrophages during infections and cancer
Wang, S., Liu, R., Yu, Q., Dong, L., Bi, Y., & Liu, G. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.03.015 · Cited by 272
Wu, Q., Zhou, W., Yin, S., Zhou, Y., Chen, T., Qian, J., Su, R., Hong, L., Lu, H., Zhang, F., et al. (2019) · Hepatology · doi:10.1002/hep.30593 · Cited by 269
IFN-γ: A cytokine at the right time, is in the right place
Burke, J. D., & Young, H. A. (2019) · Seminars in Immunology · doi:10.1016/j.smim.2019.05.002 · Cited by 254
“Additionally, their development is also favored by exposure to lactic acid and contact with apoptotic cells or damage-associated molecular patterns (DAMPs) which are distributed through tumor tissue [155,156].”
BackgroundThe Cancer Microbiome: Distinguishing Direct and Indirect Effects Requires a Systemic View
Xavier, J. B., Young, V. B., Skufca, J., Ginty, F., Testerman, T., Pearson, A. T., Macklin, P., Mitchell, A., Shmulevich, I., Xie, L., et al. (2020) · Trends in Cancer · doi:10.1016/j.trecan.2020.01.004 · Cited by 272
“Engineering a microbiome that reduces the systemic levels of metabolites, such as lactate that polarizes tumor-associated macrophages [17,18], could potentially turn off the tumorpromoting phenotypes of those macrophages.”
BackgroundCancer cell and macrophage cross-talk in the tumor microenvironment
Dehne, N., Mora, J., Namgaladze, D., Weigert, A., & Brüne, B. (2017) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2017.04.007 · Cited by 263
Targeting the Warburg Effect in Cancer: Where Do We Stand?
Barba, I., Carrillo-Bosch, L., & Seoane, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063142 · Cited by 241
“Lactate, the Warburg effect’s end-product, plays a role as an immunosuppressor in the TME [43], influencing immunotherapy resistance through metabolic crosstalk between tumor and immune cells [142,143].”
Itaconic acid mediates crosstalk between macrophage metabolism and peritoneal tumors
Weiss, J. M., Davies, L. C., Karwan, M., Ileva, L., Ozaki, M. K., Cheng, R. Y. S., Ridnour, L. A., Annunziata, C. M., Wink, D. A., & McVicar, D. W. (2018) · Journal of Clinical Investigation · doi:10.1172/jci99169 · Cited by 267
Cellular metabolism regulates the differentiation and function of T-cell subsets
Ma, S., Ming, Y., Wu, J., & Cui, G. (2024) · Cellular & Molecular Immunology · doi:10.1038/s41423-024-01148-8 · Cited by 236
“Both tumor cells and myeloid cells in tumors express arginase 1 and hydrolyze arginine [222 – 229].”
BackgroundSolute carrier transporters: the metabolic gatekeepers of immune cells
Song, W., Li, D., Tao, L., Luo, Q., & Chen, L. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.12.006 · Cited by 256
Engineering Bacteria‐Activated Multifunctionalized Hydrogel for Promoting Diabetic Wound Healing
Lu, Y., Li, H., Wang, J., Yao, M., Peng, Y., Liu, T., Li, Z., Luo, G., & Deng, J. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202105749 · Cited by 262
Biomaterials tools to modulate the tumour microenvironment in immunotherapy
Chao, Y., & Liu, Z. (2023) · Nature Reviews Bioengineering · doi:10.1038/s44222-022-00004-6 · Cited by 245
Targeting T cell metabolism for therapy
O'Sullivan, D., & Pearce, E. L. (2015) · Trends in Immunology · doi:10.1016/j.it.2014.12.004 · Cited by 254
Guglietta, S., Chiavelli, A., Zagato, E., Krieg, C., Gandini, S., Ravenda, P. S., Bazolli, B., Lu, B., Penna, G., & Rescigno, M. (2016) · Nature Communications · doi:10.1038/ncomms11037 · Cited by 255
Metabolic regulation of macrophage phenotype and function
Saha, S., Shalova, I. N., & Biswas, S. K. (2017) · Immunological Reviews · doi:10.1111/imr.12603 · Cited by 252
Fang, W., Zhou, T., Shi, H., Yao, M., Zhang, D., Qian, H., Zeng, Q., Wang, Y., Jin, F., Chai, C., et al. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01786-6 · Cited by 256
Luo, Y., Yang, Z., Yu, Y., & Zhang, P. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.10.014 · Cited by 244
ULK1-mediated metabolic reprogramming regulates Vps34 lipid kinase activity by its lactylation
Jia, M., Yue, X., Sun, W., Zhou, Q., Chang, C., Gong, W., Feng, J., Li, X., Zhan, R., Mo, K., et al. (2023) · Science Advances · doi:10.1126/sciadv.adg4993 · Cited by 234
Lactate activates the mitochondrial electron transport chain independently of its metabolism
Cai, X., Ng, C. P., Jones, O., Fung, T. S., Ryu, K. W., Li, D., & Thompson, C. B. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.09.034 · Cited by 246
Cancer Stemness Meets Immunity: From Mechanism to Therapy
Chen, P., Hsu, W.-H., Han, J., Xia, Y., & DePinho, R. A. (2021) · Cell Reports · doi:10.1016/j.celrep.2020.108597 · Cited by 252
Amino acid auxotrophy as a system of immunological control nodes
Murray, P. J. (2016) · Nature Immunology · doi:10.1038/ni.3323 · Cited by 249
Lactate at the crossroads of metabolism, inflammation, and autoimmunity
Pucino, V., Bombardieri, M., Pitzalis, C., & Mauro, C. (2017) · European Journal of Immunology · doi:10.1002/eji.201646477 · Cited by 242
“rheumatic synovial fluid) and even 30–40 mM in cancerous tissues (18, 23, 27).”
BackgroundInfluentialMetabolic reprogramming in the tumor microenvironment of liver cancer
Lin, J., Rao, D., Zhang, M., & Gao, Q. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01527-8 · Cited by 251
Unique metabolic activation of adipose tissue macrophages in obesity promotes inflammatory responses
Boutens, L., Hooiveld, G. J., Dhingra, S., Cramer, R. A., Netea, M. G., & Stienstra, R. (2018) · Diabetologia · doi:10.1007/s00125-017-4526-6 · Cited by 237
“Interestingly, leptin [24, 25] and lactate [26] have been shown capable of remodelling intracellular metabolism and changing the inflammatory state of macrophages.”
BackgroundLiu, N., Luo, J., Kuang, D., Xu, S., Duan, Y., Xia, Y., Wei, Z., Xie, X., Yin, B., Chen, F., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci123027 · Cited by 239
Intracellular and Intercellular Aspects of Macrophage Immunometabolism in Atherosclerosis
Tabas, I., & Bornfeldt, K. E. (2020) · Circulation Research · doi:10.1161/circresaha.119.315939 · Cited by 248
Macrophages and microglia: the cerberus of glioblastoma
Buonfiglioli, A., & Hambardzumyan, D. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01156-z · Cited by 238
“When secreted in the perivascular areas, IL-1β [3] and MMPs [79] produced by TAMs, and VEGFA [166] produced by TAMs and tumor cells, increase vascular permeability and edema formation S100A4 expression, and increased IL-12 levels have been shown to be associated with glioma malignancy [175, 176].”
BackgroundInfluentialComito, G., Iscaro, A., Bacci, M., Morandi, A., Ippolito, L., Parri, M., Montagnani, I., Raspollini, M. R., Serni, S., Simeoni, L., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0688-7 · Cited by 241
Kieler, M., Hofmann, M., & Schabbauer, G. (2021) · The FEBS Journal · doi:10.1111/febs.15715 · Cited by 239
Xiang, W., Shi, R., Kang, X., Zhang, X., Chen, P., Zhang, L., Hou, A., Wang, R., Zhao, Y., Zhao, K., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04999-8 · Cited by 243
Oxygen Sensing by T Cells Establishes an Immunologically Tolerant Metastatic Niche
Clever, D., Roychoudhuri, R., Constantinides, M. G., Askenase, M. H., Sukumar, M., Klebanoff, C. A., Eil, R. L., Hickman, H. D., Yu, Z., Pan, J. H., et al. (2016) · Cell · doi:10.1016/j.cell.2016.07.032 · Cited by 242
“HIF also promotes the development of immunosuppressive macrophages (Colegio et al., 2014; Doedens et al., 2010).”
BackgroundMetabolic reprogramming in triple-negative breast cancer
Sun, X., Wang, M., Wang, M., Yu, X., Guo, J., Sun, T., Li, X., Yao, L., Dong, H., & Xu, Y. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00428 · Cited by 243
Conde, J., Bao, C., Tan, Y., Cui, D., Edelman, E. R., Azevedo, H. S., Byrne, H. J., Artzi, N., & Tian, F. (2015) · Advanced Functional Materials · doi:10.1002/adfm.201501283 · Cited by 238
Metabolic networks in mutant KRAS-driven tumours: tissue specificities and the microenvironment
Kerk, S. A., Papagiannakopoulos, T., Shah, Y. M., & Lyssiotis, C. A. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00375-9 · Cited by 237
Exploiting innate immunity for cancer immunotherapy
Yi, M., Li, T., Niu, M., Mei, Q., Zhao, B., Chu, Q., Dai, Z., & Wu, K. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01885-w · Cited by 225
Ma, G., Zhang, Z., Li, P., Zhang, Z., Zeng, M., Liang, Z., Li, D., Wang, L., Chen, Y., Liang, Y., et al. (2022) · Cell Communication and Signaling · doi:10.1186/s12964-022-00909-0 · Cited by 230
“However, whether and how glutamine metabolism regulates the tumor-promoting function of TAMs remains to be further demonstrated [99].”
BackgroundColonic macrophage polarization in homeostasis, inflammation, and cancer
Isidro, R. A., & Appleyard, C. B. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00123.2016 · Cited by 229
Recent therapeutic trends and promising targets in triple negative breast cancer
Hwang, S.-Y., Park, S., & Kwon, Y. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.02.006 · Cited by 232
Macrophage Biology and Mechanisms of Immune Suppression in Breast Cancer
Mehta, A. K., Kadel, S., Townsend, M. G., Oliwa, M., & Guerriero, J. L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.643771 · Cited by 231
“In line with this, in areas of hypoxia, TAMs upregulate HIF-1α, which enables migration and survival (130), suggesting a feedback loop and signaling between tumor cells and TAMs that regulate their metabolic phenotype.”
BackgroundDysregulated bioenergetics: a key regulator of joint inflammation
Biniecka, M., Canavan, M., McGarry, T., Gao, W., McCormick, J., Cregan, S., Gallagher, L., Smith, T., Phelan, J. J., Ryan, J., et al. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-208476 · Cited by 236
The role of tumor-associated macrophages in tumor immune evasion
Huang, R., Kang, T., & Chen, S. (2024) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-024-05777-4 · Cited by 230
“For example, lactic acid produced by cancer cell glycolysis can induce the upregulation of hypoxia-inducible factor-1 alpha (HIF-1α) in TAM, thereby enhancing the expression of glycolysis gene and M2-like state, thereby promoting tumor progression, angiogenesis and epithelial-mesenchymal transformation (EMT) (Colegio…”
BackgroundLung adenocarcinoma distally rewires hepatic circadian homeostasis
Masri, S., Papagiannakopoulos, T., Kinouchi, K., Liu, Y., Cervantes, M., Baldi, P., Jacks, T., & Sassone-Corsi, P. (2016) · Cell · doi:10.1016/j.cell.2016.04.039 · Cited by 234
“…lactate, a product of increased aerobic glycolysis of cancer cells, is associated with heightened metastatic incidence, increased angiogenesis, is responsible for metabolic reprogramming in adjacent tissues and can induce a pro-inflammatory state (Colegio et al., 2014; Doherty and Cleveland, 2013).”
Tamura, R., Tanaka, T., Akasaki, Y., Murayama, Y., Yoshida, K., & Sasaki, H. (2020) · Medical Oncology · doi:10.1007/s12032-019-1329-2 · Cited by 226
“VEGF in the hypoxic TME is a key factor for transitioning from the M1 to M2 macrophage phenotype [33].”
BackgroundDecoding the spatiotemporal heterogeneity of tumor-associated macrophages
Chu, X., Tian, Y., & Lv, C. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02064-1 · Cited by 214
“Lactate, a by-product of both aerobic and anaerobic glycolysis from tumor cells, plays a crucial role by inducing VEGF expression and M2-like polarization of TAMs [56].”
BackgroundDeng, R.-H., Zou, M.-Z., Zheng, D., Peng, S.-Y., Liu, W., Bai, X.-F., Chen, H.-S., Sun, Y., Zhou, P.-H., & Zhang, X.-Z. (2019) · ACS Nano · doi:10.1021/acsnano.9b02993 · Cited by 230
Lactate, histone lactylation and cancer hallmarks
Lv, X., Lv, Y., & Dai, X. (2023) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2022.42 · Cited by 210
“35).”
Hypoxia and acidosis: immune suppressors and therapeutic targets
Damgaci, S., Ibrahim‐Hashim, A., Enriquez‐Navas, P. M., Pilon‐Thomas, S., Guvenis, A., & Gillies, R. J. (2018) · Immunology · doi:10.1111/imm.12917 · Cited by 231
HIF-1α Is an Essential Mediator of IFN-γ–Dependent Immunity to Mycobacterium tuberculosis
Braverman, J., Sogi, K. M., Benjamin, D., Nomura, D. K., & Stanley, S. A. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600266 · Cited by 233
Cancer Cells Don’t Live Alone: Metabolic Communication within Tumor Microenvironments
Li, F., & Simon, M. C. (2020) · Developmental Cell · doi:10.1016/j.devcel.2020.06.018 · Cited by 221
“IL10), and metabolites like polyamines, which are essential for cell division (Colegio et al., 2014).”
BackgroundCancer metabolism in space and time: Beyond the Warburg effect
Danhier, P., Bański, P., Payen, V. L., Grasso, D., Ippolito, L., Sonveaux, P., & Porporato, P. E. (2017) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2017.02.001 · Cited by 214
Lactate and Immunosuppression in Sepsis
Nolt, B., Tu, F., Wang, X., Ha, T., Winter, R., Williams, D. L., & Li, C. (2018) · Shock · doi:10.1097/shk.0000000000000958 · Cited by 219
Innate Immunity and Cancer Pathophysiology
Maiorino, L., Daßler-Plenker, J., Sun, L., & Egeblad, M. (2022) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-032221-115501 · Cited by 215
Myeloid cell-targeted therapies for solid tumours
Goswami, S., Anandhan, S., Raychaudhuri, D., & Sharma, P. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00737-w · Cited by 220
Pan, T., Sun, S., Chen, Y., Tian, R., Chen, E., Tan, R., Wang, X., Liu, Z., Liu, J., & Qu, H. (2022) · Critical Care · doi:10.1186/s13054-022-03893-6 · Cited by 212
Tumor-associated myeloid cells: diversity and therapeutic targeting
Mantovani, A., Marchesi, F., Jaillon, S., Garlanda, C., & Allavena, P. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-00613-4 · Cited by 219
Metabolic Cooperation and Competition in the Tumor Microenvironment: Implications for Therapy
Gupta, S., Roy, A., & Dwarakanath, B. S. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00068 · Cited by 218
“In addition to reprograming of glycolytic pathways, it is suggested that tumor cells might also induce glutamine addiction in the neighboring CAFs and TAMs.”
BackgroundInfluentialLecoultre, M., Dutoit, V., & Walker, P. R. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001408 · Cited by 223
Zhang, Y.-X., Zhao, Y.-Y., Shen, J., Sun, X., Liu, Y., Liu, H., Wang, Y., & Wang, J. (2019) · Nano Letters · doi:10.1021/acs.nanolett.8b04296 · Cited by 220
Evaluation of the association of chronic inflammation and cancer: Insights and implications
Nigam, M., Mishra, A. P., Deb, V. K., Dimri, D. B., Tiwari, V., Bungau, S. G., Bungau, A. F., & Radu, A.-F. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115015 · Cited by 205
Bruno, A., Mortara, L., Baci, D., Noonan, D. M., & Albini, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00771 · Cited by 215
Cancer Stem Cells and Immunosuppressive Microenvironment in Glioma
Ma, Q., Long, W., Xing, C., Chu, J., Luo, M., Wang, H. Y., Liu, Q., & Wang, R.-F. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02924 · Cited by 219
“directly inhibit CD8 T-cell function and stimulate TAMs to promote tumor growth (123).”
BackgroundHayes, C., Donohoe, C. L., Davern, M., & Donlon, N. E. (2021) · Cancer Letters · doi:10.1016/j.canlet.2020.12.021 · Cited by 213
Pugliese, S. C., Poth, J. M., Fini, M. A., Olschewski, A., El Kasmi, K. C., & Stenmark, K. R. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00238.2014 · Cited by 214
Metabolic Control of Dendritic Cell Functions: Digesting Information
Wculek, S. K., Khouili, S. C., Priego, E., Heras-Murillo, I., & Sancho, D. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00775 · Cited by 215
“Moreover, HIF1α can be activated by intracellular pyruvate or lactate produced by glycolysis (70, 71).”
Lactate dehydrogenase: a marker of diminished antitumor immunity
Van Wilpe, S., Koornstra, R., Den Brok, M., De Groot, J. W., Blank, C., De Vries, J., Gerritsen, W., & Mehra, N. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1731942 · Cited by 208
“(TAMs), which can have pro-inflammatory (M1) or immune suppressive (M2) phenotypes, into M2 macrophages.(44)”
BackgroundXiao, J., Wang, S., Chen, L., Ding, X., Dang, Y., Han, M., Zheng, Y., Shen, H., Wu, S., Wang, M., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.03.021 · Cited by 189
Trends and Challenges in Tumor Anti-Angiogenic Therapies
Jászai, J., & Schmidt, M. (2019) · Cells · doi:10.3390/cells8091102 · Cited by 208
“The acidic tumor microenviroment represents a direct trigger for M2-like polarization and the VEGF-expression of TAMs via HIF1, which contributes to the maintenance of immunosuppression [209].”
BackgroundModification of Proteins by Metabolites in Immunity
Diskin, C., Ryan, T. A. J., & O’Neill, L. A. J. (2021) · Immunity · doi:10.1016/j.immuni.2020.09.014 · Cited by 209
Zhang, A., Xu, Y., Xu, H., Ren, J., Meng, T., Ni, Y., Zhu, Q., Zhang, W.-B., Pan, Y.-B., Jin, J., et al. (2021) · Theranostics · doi:10.7150/thno.53749 · Cited by 209
“Lactate specifically biases TAMs towards a “tumorfriendly” M2-like phenotype, which contributes to tumor cells evading immunosurveillance [37].”
Metabolic Barriers to T Cell Function in Tumors
Sugiura, A., & Rathmell, J. C. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701041 · Cited by 208
“Additionally, lactate has been shown to stabilize HIF1a in macrophages (74), and can be predicted to have similar effects in T cells.”
BackgroundMetabolism in tumor microenvironment: Implications for cancer immunotherapy
Shi, R., Tang, Y., & Miao, H. (2020) · MedComm · doi:10.1002/mco2.6 · Cited by 198
“The expression of glutamine transporter and metabolic enzymes are significantly increased in TAM, which is beneficial for M2 polarization.(34,86) TAMs upregulate the indoleamine 2,3-dioxygenase (IDO) and the rate limiting enzyme of Trp and inhibit the tumor immune response, thus promoting the malignant progression of…”
BackgroundHe, Z., & Zhang, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.741305 · Cited by 203
Wang, T., Ye, Z., Li, Z., Jing, D., Fan, G., Liu, M., Zhuo, Q., Ji, S., Yu, X., Xu, X., et al. (2023) · Cell Proliferation · doi:10.1111/cpr.13478 · Cited by 192
“71 VEGF in macrophages induces the formation of the new blood vessel, and Arg 1 provides a substrate for cancer cell proliferation to support tumour growth.”
InfluentialStienstra, R., Netea-Maier, R. T., Riksen, N. P., Joosten, L. A. B., & Netea, M. G. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.06.001 · Cited by 194
Understanding lactate sensing and signalling
Certo, M., Llibre, A., Lee, W., & Mauro, C. (2022) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2022.07.004 · Cited by 189
“Lactate-driven stabilization of HIF-1α in macrophages has been linked to tumour angiogenesis and growth [124,125].”
BackgroundMCT4-dependent lactate secretion suppresses antitumor immunity in LKB1-deficient lung adenocarcinoma
Qian, Y., Galan-Cobo, A., Guijarro, I., Dang, M., Molkentine, D., Poteete, A., Zhang, F., Wang, Q., Wang, J., Parra, E., et al. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.05.015 · Cited by 193
Lactate limits CNS autoimmunity by stabilizing HIF-1α in dendritic cells
Sanmarco, L. M., Rone, J. M., Polonio, C. M., Fernandez Lahore, G., Giovannoni, F., Ferrara, K., Gutierrez-Vazquez, C., Li, N., Sokolovska, A., Plasencia, A., et al. (2023) · Nature · doi:10.1038/s41586-023-06409-6 · Cited by 193
High fat diet, gut microbiome and gastrointestinal cancer
Tong, Y., Gao, H., Qi, Q., Liu, X., Li, J., Gao, J., Li, P., Wang, Y., Du, L., & Wang, C. (2021) · Theranostics · doi:10.7150/thno.56157 · Cited by 205
“For example, while HFD can cause abnormal accumulation of bile acids under the action of microorganisms, and Cui et al. found that the liver FGF15 (19)/FGFR4 signal is significantly enhanced by HFD, we infer that bile acids enhance FGF15 (19)/FGFR4 and then activate EMT and the Wnt/β-catenin pathway, leading to the ca…”
BackgroundInfluentialMarigo, I., Zilio, S., Desantis, G., Mlecnik, B., Agnellini, A. H. R., Ugel, S., Sasso, M. S., Qualls, J. E., Kratochvill, F., Zanovello, P., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.08.004 · Cited by 203
“Akey inhibitory pathway in the tumor microenvironment involves the metabolism of arginine through regulated expression of two enzymes: arginase 1 (ARG1, encoded byARG1) hydrolyzes arginine while nitric oxide synthase 2 (NOS2, also known as inducible NOS or iNOS, encoded by NOS2) generates nitric oxide (NO) from argini…”
InfluentialThe emerging role of lactate in tumor microenvironment and its clinical relevance
Chen, S., Xu, Y., Zhuo, W., & Zhang, L. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216837 · Cited by 194
Rubenstein, J. L., Geng, H., Fraser, E. J., Formaker, P., Chen, L., Sharma, J., Killea, P., Choi, K., Ventura, J., Kurhanewicz, J., et al. (2018) · Blood Advances · doi:10.1182/bloodadvances.2017014845 · Cited by 199
Macrophage polarization in the tumor microenvironment: Emerging roles and therapeutic potentials
Zhang, W., Wang, M., Ji, C., Liu, X., Gu, B., & Dong, T. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116930 · Cited by 178
Formentini, L., Santacatterina, F., Núñez de Arenas, C., Stamatakis, K., López-Martínez, D., Logan, A., Fresno, M., Smits, R., Murphy, M. P., & Cuezva, J. M. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.04.036 · Cited by 199
“Indeed, mtROS and other metabolites derived from mitochondrial activity are critical elements for innate and adaptive immune responses (Colegio et al., 2014; O’Neill, 2014; Osborn and Olefsky, 2012; Weinberg et al., 2015; West et al., 2015).”
BackgroundPan, W., Zhu, S., Qu, K., Meeth, K., Cheng, J., He, K., Ma, H., Liao, Y., Wen, X., Roden, C., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.07.020 · Cited by 198
“These results are consistent with myeloid Arg1 promoting tumor growth in a lung tumor model in vivo (Colegio et al., 2014; Rodriguez et al., 2005) and that Arg1 catalyzes the degradation of L-arginine from the extracellular environment to decrease antigen-specific T cell proliferation (Pauleau et al.”
Influential
Metadata
- Authors
- Colegio, O. R., Chu, N.-Q., Szabo, A. L., Chu, T., Rhebergen, A. M., Jairam, V., Cyrus, N., Brokowski, C. E., Eisenbarth, S. C., Phillips, G. M., Cline, G. W., Phillips, A. J., & Medzhitov, R.
- Affiliations
- Yale Cancer Center (US)
- Yale University (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Medzhitov, Ruslan
- ORCID
- Venue
- Nature
- Published
- 2014-07-13
- Volume
- 513
- Issue
- 7519
- Pages
- 559-563
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4301845
- OpenAlex
- W2063632665
- Cited by
- 3,046
- References
- 24
- Citations by year
- 2026: 359 · 2025: 338 · 2024: 311 · 2023: 338 · 2022: 345 · 2021: 314 · 2020: 269 · 2019: 213 · 2018: 159 · 2017: 161 · 2016: 113 · 2015: 87 · 2014: 23
- FWCI
- 58.50
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health (UL1TR000142)
- National Cancer Institute (R01CA157461, K08CA172580, P50CA121974, CA157461)
- National Institute of Allergy and Infectious Diseases (AI089771, R01AI089771, R37AI046688, AI046688, R01AI046688)
- National Center for Research Resources (KL2RR024138)
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- tumour-associated macrophages, lactic acid, M2 macrophage polarization, hypoxia-inducible factor-1α, vascular endothelial growth factor, arginase-1, tumor growth, tumor microenvironment, glycolysis, tissue homeostasis
- MeSH terms
- Animals, Arginase, Cell Communication, Cell Division, Female, Glycolysis, Homeostasis, Macrophages, Male, Melanoma, Experimental, Mice, Inbred BALB C, Mice, Inbred C57BL, Neoplasms, RNA, Messenger, Solubility, Up-Regulation, Culture Media, Conditioned, Carcinoma, Lewis Lung, Lactic Acid, Vascular Endothelial Growth Factor A, Mice, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.